Sala, R.; Esquer, H.; Kellett, T.; Clune, S.; Awolade, P.; Pike, L.A.; Zhou, Q.; Messersmith, W.A.; LaBarbera, D.V.
CHD1L Inhibitor OTI-611 Synergizes with Chemotherapy to Enhance Antitumor Efficacy and Prolong Survival in Colorectal Cancer Mouse Models. Int. J. Mol. Sci. 2024, 25, 13160.
https://doi.org/10.3390/ijms252313160
AMA Style
Sala R, Esquer H, Kellett T, Clune S, Awolade P, Pike LA, Zhou Q, Messersmith WA, LaBarbera DV.
CHD1L Inhibitor OTI-611 Synergizes with Chemotherapy to Enhance Antitumor Efficacy and Prolong Survival in Colorectal Cancer Mouse Models. International Journal of Molecular Sciences. 2024; 25(23):13160.
https://doi.org/10.3390/ijms252313160
Chicago/Turabian Style
Sala, Rita, Hector Esquer, Timothy Kellett, Sophia Clune, Paul Awolade, Laura A. Pike, Qiong Zhou, Wells A. Messersmith, and Daniel V. LaBarbera.
2024. "CHD1L Inhibitor OTI-611 Synergizes with Chemotherapy to Enhance Antitumor Efficacy and Prolong Survival in Colorectal Cancer Mouse Models" International Journal of Molecular Sciences 25, no. 23: 13160.
https://doi.org/10.3390/ijms252313160
APA Style
Sala, R., Esquer, H., Kellett, T., Clune, S., Awolade, P., Pike, L. A., Zhou, Q., Messersmith, W. A., & LaBarbera, D. V.
(2024). CHD1L Inhibitor OTI-611 Synergizes with Chemotherapy to Enhance Antitumor Efficacy and Prolong Survival in Colorectal Cancer Mouse Models. International Journal of Molecular Sciences, 25(23), 13160.
https://doi.org/10.3390/ijms252313160
